follicular lymphoma

With Jakafi's patent cliff looming, Incyte looks to 2025 launches to bulk up revenue by decade's end
Fierce Pharma
Wed, 10/30/24 - 11:42 am
Incyte
Jakafi
patent cliff
Niktimvo
graft vs host disease
Monjuvi
follicular lymphoma
Zynyz
squamous cell anal carcinoma
FDA approves expanded use of Bristol Myers' cancer cell therapy
Reuters
Wed, 05/15/24 - 10:48 pm
Brisstol Myers Squibb
cell therapy
Breyanzi
follicular lymphoma
AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug
BioSpace
Thu, 06/29/23 - 11:15 pm
AbbVie
Genmab
Roche
follicular lymphoma
bispecific antibodies
epcoritamab
Lunsumio
Roche gets FDA nod for Lunsumio, offering convenient option to gene therapies in follicular lymphoma
Fierce Pharma
Wed, 12/28/22 - 08:32 pm
Roche
FDA
Lunsumio
gene therapy
follicular lymphoma
FDA to decide on Roche’s lymphoma drug Lunsumio before year-end
Pharmaforum
Wed, 07/6/22 - 10:49 am
Roche
Lunsumio
follicular lymphoma
T-cell engager
FDA
priority review
Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect
Fierce Biotech
Tue, 11/30/21 - 10:41 am
MEI Pharma
blood cancer
follicular lymphoma
zandelisib
Bayer
Gilead Sciences
Epizyme pairs real-life nurse with interactive tool to help follicular lymphoma patients navigate the tough questions
Fierce Pharma
Fri, 11/19/21 - 11:14 am
Epizyme
pharma marketing
follicular lymphoma
#ASCO21: Novartis gears up for CAR-T fight with Gilead in follicular lymphoma — and safety could define the battle
Endpoints
Thu, 06/3/21 - 10:51 am
Novartis
ASCO 2021
CAR-T
Kymriah
follicular lymphoma
Gilead Sciences
Yescarta
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
Fierce Pharma
Sun, 04/11/21 - 11:36 pm
AACR
Bayer
Aliqopa
non-Hodgkin lymphoma
follicular lymphoma
Zydelig
Watch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rivalrnings season continues to show COVID-19 uncertainty
Fierce Pharma
Mon, 02/8/21 - 10:38 pm
TG Therapeutics
FDA
Ukoniq
umbralisib
follicular lymphoma
marginal zone lymphoma
Gilead Sciences
ASH: Novartis makes its Kymriah case in follicular lymphoma, but another Gilead showdown awaits
Fierce Pharma
Sat, 12/5/20 - 11:38 pm
ASH2020
Novartis
Kymriah
follicular lymphoma
clinical trials
Gilead’s Kite submits FDA approval application for CAR-T in slow-growing lymphomas
MedCity News
Tue, 09/8/20 - 10:40 am
Gilead Sciences
Yescarta
follicular lymphoma
marginal zone lymphoma
ASCO 2020
Kite Pharma
Novartis says CAR-T cancer therapy works in second lymphoma type
BioPharma Dive
Tue, 08/4/20 - 12:40 pm
Novartis
Kymriah
follicular lymphoma
CAR-T
Epizyme's Tazverik Wins FDA Approval to Treat Follicular Lymphoma
Motley Fool
Thu, 06/18/20 - 08:29 pm
Epizyme
FDA
Tazverik
follicular lymphoma
FDA hastens development of Novartis’ Kymriah in follicular lymphoma
Pharmaforum
Wed, 04/22/20 - 10:35 am
Novartis
Kymriah
follicular lymphoma
FDA
regenerative medicine
Epizyme eyes lucrative use for newly-launched Tazverik
Pharmaforum
Tue, 02/18/20 - 10:22 am
Epizyme
FDA
Tazverik
follicular lymphoma
Epizyme's Cancer Drug to Get Rapid FDA Review for a New Indication
Motley Fool
Fri, 02/14/20 - 04:58 pm
Epizyme
FDA
tazemetostat
follicular lymphoma
Xynomic Pharma Files For $65 Million Offering
CP Wire
Thu, 07/11/19 - 09:47 am
Xynomic Pharma
renal cell carninoma
diffuse large B-cell lymphoma
follicular lymphoma
Xynomic Pharma Files For $65 Million Offering
Thu, 07/11/19 - 09:44 am
Xynomic Pharma
renal cell carninoma
diffuse large B-cell lymphoma
follicular lymphoma
Celgene gets FDA nod for blood cancer drug combo Revlimid plus rituximab
Pharmaceutical Business Review
Wed, 05/29/19 - 09:55 am
Celgene
Revlimid
follicular lymphoma
marginal zone lymphoma

Pages